c4c: Paediatric pharmacovigilance: Methodological considerations in research and development of medicines for children - A c4c expert group white paper.
Br J Clin Pharmacol
; 88(12): 4997-5016, 2022 12.
Article
in En
| MEDLINE
| ID: mdl-34699077
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drug-Related Side Effects and Adverse Reactions
/
Pharmacovigilance
Type of study:
Guideline
/
Risk_factors_studies
Limits:
Adult
/
Child
/
Humans
Language:
En
Journal:
Br J Clin Pharmacol
Year:
2022
Type:
Article
Affiliation country:
France